Condensed Consolidated Statements of Cash Flows - USD ($) $ in Thousands	6 Months Ended
	Jun. 30, 2025	Jun. 30, 2024
Cash flows from operating activities:
Net income (loss)	$ 4,494	$ (50,153)
Adjustments to reconcile net income (loss) to net cash provided by operating activities:
Depreciation and amortization	13,146	13,175
Amortization of deferred contract costs	31,612	28,642
Stock-based compensation	35,387	47,022
Allowance for credit losses	2,391	743
Net (accretion) amortization of marketable securities	(2,134)	(4,450)
Non-cash operating lease expense	1,846	2,732
Unrealized loss on strategic investments	0	10,311
Other	623	502
Changes in operating assets and liabilities:
Accounts receivable	1,384	9,732
Prepaid expenses and other assets	(413)	(545)
Deferred contract costs	(34,992)	(32,734)
Accounts payable, accrued expenses and other liabilities	(10,196)	2,937
Content costs payable	(4,439)	(4,627)
Operating lease liabilities	(1,611)	(3,539)
Deferred revenue	19,315	29,813
Net cash provided by operating activities	56,413	49,561
Cash flows from investing activities:
Purchases of marketable securities	(112,505)	(146,378)
Proceeds from maturities of marketable securities	116,700	173,550
Purchases of property and equipment	(4,661)	(554)
Capitalized software costs	(5,651)	(6,711)
Payments related to asset acquisitions	(1,500)	0
Net cash provided by (used in) investing activities	(7,617)	19,907
Cash flows from financing activities:
Net proceeds from exercise of stock options	49	439
Proceeds from share purchases under employee stock purchase plan	2,560	4,533
Taxes paid related to net share settlement of equity awards	(9,917)	(19,815)
Repurchases of common stock and excise taxes paid	(875)	(90,577)
Payments of debt issuance costs	(1,219)	0
Net cash used in financing activities	(9,402)	(105,420)
Effect of foreign exchange rates on cash flows	172	(21)
Net increase (decrease) in cash, cash equivalents and restricted cash	39,566	(35,973)
Cash, cash equivalents and restricted cash—Beginning of period	191,807	309,552
Cash, cash equivalents and restricted cash—End of period	231,373	273,579
Reconciliation of cash, cash equivalents and restricted cash:
Cash and cash equivalents	230,258	272,364
Restricted cash, current	203	100
Restricted cash, non-current	912	1,115
Total cash, cash equivalents and restricted cash	231,373	273,579
Supplemental disclosures of cash flow information:
Interest paid	0	0
Income taxes paid	1,112	602
Supplemental disclosure of non-cash investing and financing activities:
Stock-based compensation in capitalized costs	3,304	4,627
Net change in unrealized gain (loss) on marketable securities	(64)	(92)
Increase (decrease) in purchases of property and equipment included in liabilities	(354)	347
Unpaid debt issuance costs	220	0
Operating lease right-of-use assets exchanged for operating lease liabilities	$ 0	$ 9,779